Continuous manufacturing and product-process archetypes: implications for supply network design in Pharma

Tomás Seosamh Harrington; Leila Alinaghian; Jagjit Singh Srai

Continuous manufacturing and product-process archetypes: implications for supply network design in Pharma

Tomás Seosamh Harrington (Lead Author), Leila Alinaghian, Jagjit Singh Srai

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

15 Downloads (Pure)

Abstract

Continuous Manufacturing has enabled the potential for significant step changes within the Pharmaceutical industry. However, adoption rates remain in the range of 5%. This research examines the challenges and implications of the shift from ‘batch’ to ‘continuous’ processing in terms of e.g. product variety and supply network design.

Original language	English
Title of host publication	24th Annual Production and Operations Management Society (POMS) conference
Publication status	Published - 2013
Event	24th Annual Production and Operations Management Society (POMS) conference - Denver, United States Duration: 3 May 2013 → 6 May 2013

Conference

Conference	24th Annual Production and Operations Management Society (POMS) conference
Country/Territory	United States
City	Denver
Period	3/05/13 → 6/05/13

Access to Document

Conference paperAccepted author manuscript, 510 KB

1 Article

Convergence of product, production, and supply chain design rules: Evidence from pharmaceutical pre-competitive collaboration networks
Singh Srai, J., Harrington, T., Joglekar, N. R. & Narayanan, S., 26 Feb 2025, (E-pub ahead of print) In: Journal of Operations Management.
Research output: Contribution to journal › Article › peer-review

Open Access
File

1 Downloads (Pure)

Cite this

@inproceedings{45481fc68a744987b29f92efa169a7c7,

title = "Continuous manufacturing and product-process archetypes: implications for supply network design in Pharma",

abstract = "Continuous Manufacturing has enabled the potential for significant step changes within the Pharmaceutical industry. However, adoption rates remain in the range of 5%. This research examines the challenges and implications of the shift from {\textquoteleft}batch{\textquoteright} to {\textquoteleft}continuous{\textquoteright} processing in terms of e.g. product variety and supply network design.",

author = "Harrington, {Tom{\'a}s Seosamh} and Leila Alinaghian and {Singh Srai}, Jagjit",

year = "2013",

language = "English",

booktitle = "24th Annual Production and Operations Management Society (POMS) conference",

note = "24th Annual Production and Operations Management Society (POMS) conference ; Conference date: 03-05-2013 Through 06-05-2013",

}

TY - GEN

T1 - Continuous manufacturing and product-process archetypes: implications for supply network design in Pharma

AU - Harrington, Tomás Seosamh

AU - Alinaghian, Leila

AU - Singh Srai, Jagjit

PY - 2013

Y1 - 2013

N2 - Continuous Manufacturing has enabled the potential for significant step changes within the Pharmaceutical industry. However, adoption rates remain in the range of 5%. This research examines the challenges and implications of the shift from ‘batch’ to ‘continuous’ processing in terms of e.g. product variety and supply network design.

AB - Continuous Manufacturing has enabled the potential for significant step changes within the Pharmaceutical industry. However, adoption rates remain in the range of 5%. This research examines the challenges and implications of the shift from ‘batch’ to ‘continuous’ processing in terms of e.g. product variety and supply network design.

M3 - Conference contribution

BT - 24th Annual Production and Operations Management Society (POMS) conference

T2 - 24th Annual Production and Operations Management Society (POMS) conference

Y2 - 3 May 2013 through 6 May 2013

ER -

Continuous manufacturing and product-process archetypes: implications for supply network design in Pharma

Abstract

Conference

Access to Document

Research output

Convergence of product, production, and supply chain design rules: Evidence from pharmaceutical pre-competitive collaboration networks

Cite this